logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12558363 B1

PDFFull Text
Date of Patent:
Feb. 24, 2026

Filed:

Dec. 29, 2020

Compositions for clinical complications associated to devices implanted in the urinary tract

Applicants:

Devicare SL, Cerdanyola del Vallès, ES;

Universidad DE Les Illes Balears, Palma de Mallorca, ES;

Inventors:

Felix Grases Freixedas, Palma de Mallorca, ES;

Jordi Cuñe Castellana, Cerdanyola del Vallès, ES;

Antonia Costa-Bauzá, Palma de Mallorca, ES;

Paula Calvó García, Palma de Mallorca, ES;

Sebastián Albertí Serrano, Palma de Mallorca, ES;

Margalida Mateu Borrás, Palma de Mallorca, ES;

Assignees:

Devicare SL, Cerdanyola del Vallès, ES;

Universidad De Les Illes Balears, Palma de Mallorca, ES;

Attorneys:

STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.

Jaume M. Canaves

Primary Examiner:

Melissa S Mercier

Int. Cl.
CPC ...
A61K 31/6615 (2006.01); A61K 31/197 (2006.01); A61K 31/522 (2006.01); A61L 29/08 (2006.01); A61L 29/16 (2006.01); A61P 13/02 (2006.01); A61P 31/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/6615 (2013.01); A61K 31/197 (2013.01); A61K 31/522 (2013.01); A61L 29/08 (2013.01); A61L 29/16 (2013.01); A61P 13/02 (2018.01); A61P 31/04 (2018.01); A61L 2300/204 (2013.01); A61L 2300/214 (2013.01); A61L 2300/216 (2013.01); A61L 2300/404 (2013.01);
Abstract

It is provided a composition comprising phytic acid or a pharmaceutically acceptable salt thereof, for use in reducing or preventing microorganisms' proliferation and/or encrustations caused by a urinary tract device implanted in a subject, thereby preventing or treating clinical complications related to microorganisms' proliferation and/or encrustations. The composition can further comprise a urine acidifier such as methionine, a crystallization inhibitor such as theobromine and/or other agents.

Find Patent Forward Citations

Quick Actions:

Grases Freixedas, Felix. (2026). Compositions for clinical complications associated to devices implanted in the urinary tract (U.S. Patent No. 12558363). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12558363

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…